Published in Int J Hematol on February 01, 2001
Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms. J Clin Oncol (2011) 1.51
Prognostic model to identify patients with myelofibrosis at the highest risk of transformation to acute myeloid leukemia. Clin Lymphoma Myeloma Leuk (2013) 0.85
(18)F-FDG PET/CT for Detection of Metachronous Hodgkin's Disease in Patients with Myelofibrosis. Nucl Med Mol Imaging (2014) 0.75
Acute Myeloid Leukemia Evolving from JAK 2-Positive Primary Myelofibrosis and Concomitant CD5-Negative Mantle Cell Lymphoma: A Case Report and Review of the Literature. Case Rep Hematol (2012) 0.75
Pulmonary Hypertension Associated with Pulmonary Veno-occlusive Disease in Patients with Polycythemia Vera. Intern Med (2017) 0.75
Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program. N Engl J Med (1998) 3.62
Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood (2001) 3.07
Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay. Virology (1999) 2.21
Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum (1999) 2.18
Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma. Cancer Res (1993) 2.01
Progressive impairment of kidneys and reproductive organs in mice lacking Rho GDIalpha. Oncogene (1999) 1.91
Brief report: severe infectious mononucleosis-like syndrome and primary human herpesvirus 6 infection in an adult. N Engl J Med (1993) 1.84
Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology (1995) 1.72
Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function. Immunity (2000) 1.69
Variable mutations of the RB gene in small-cell lung carcinoma. Oncogene (1990) 1.63
Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma. J Gastroenterol Hepatol (2001) 1.63
HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J Exp Med (1995) 1.61
Superior outcome of infant acute myeloid leukemia with intensive chemotherapy: results of the Japan Infant Leukemia Study Group. Blood (2001) 1.61
Decreased expression of an ATP-binding cassette transporter, MRP2, in human livers with hepatitis C virus infection. J Hepatol (2001) 1.54
Inverse correlation between the expression of bcl-2 and p53 proteins in primary gastric lymphoma. Hum Pathol (1996) 1.53
Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors. The Fukuoka Bone Marrow Transplantation Group. Bone Marrow Transplant (1997) 1.53
Clinical characteristics of Japanese patients with primary myelodysplastic syndromes: a co-operative study based on 838 cases. Anemia Study Group of the Ministry of Health and Welfare. Leuk Res (1995) 1.48
Rapid somatic growth after birth in children with neuroblastoma: A survey of 1718 patients with childhood cancer in Kyushu-Okinawa district. J Pediatr (1999) 1.47
Sinus arrest during tacrolimus (FK506) and digitalis treatment in a bone marrow transplant recipient. Transplantation (1997) 1.46
Dermatomyositis associated with invasive thymoma. Intern Med (1999) 1.45
Acute 'bilineal-biphenotypic' leukaemia. Br J Haematol (1990) 1.42
Successful treatment of refractory anemia with high-dose methylprednisolone. Am J Hematol (1990) 1.41
Early viral complications following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma. Br J Haematol (1998) 1.41
Production of anti-cardiolipin antibody in AKR/J mice with streptozocin-induced insulitis and diabetes. Diabetes Res Clin Pract (1993) 1.40
Pericentric inversion of chromosome 16 and eosinophilia in chronic myelomonocytic leukemia. Cancer Genet Cytogenet (1997) 1.40
Relationship of infused CFU-GM and CFU-Mk mobilized by chemotherapy with or without G-CSF to platelet recovery after autologous blood stem cell transplantation. Exp Hematol (1995) 1.39
Production of macrophage colony-stimulating factor by human lymphoblastoid cell lines. Leuk Res (1991) 1.39
Vector manometric study of the sphincter of Oddi in the dog: functional and morphological correlation. J Gastroenterol (1998) 1.39
Effect of thrombopoietin on proliferation of blasts from CD7-positive acute myelogenous leukaemia. Br J Haematol (1998) 1.39
Effects of macrophage colony-stimulating factor (M-CSF) on the mobilization of peripheral blood stem cells. Bone Marrow Transplant (1994) 1.39
Gastrointestinal angiodysplasia in congenital platelet dysfunction. Int J Hematol (1996) 1.39
Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments. Cancer (1996) 1.36
C5a induces tissue factor activity on endothelial cells. Thromb Haemost (1997) 1.34
Alterations in T cell receptor and signal transduction molecules in melanoma patients. Clin Cancer Res (1995) 1.33
gamma-Glutamyl dopa: a kidney-specific dopamine precursor. J Pharmacol Exp Ther (1978) 1.30
Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia. Blood (1998) 1.30
The effect of a multiple literature database search--a numerical evaluation in the domain of Japanese life science. J Med Syst (1992) 1.29
A new technique for the cytochemical examination of human hemopoietic cells grown in agar gel. Exp Hematol (1980) 1.29
Studies of leukemic cell populations in culture. Blood (1974) 1.29
Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice. Int Immunol (1997) 1.29
A clinical comparison of definite moyamoya disease between South Korea and Japan. Stroke (1997) 1.25
Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. J Biol Chem (1993) 1.25
Prognostic significance of polo-like kinase expression in esophageal carcinoma. Int J Oncol (1999) 1.24
Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis. Br J Dermatol (2003) 1.24
A simplified method for cryopreservation of peripheral blood stem cells at -80 degrees C without rate-controlled freezing. Bone Marrow Transplant (1991) 1.22
Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem Biophys Res Commun (1992) 1.20
Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia. Blood (1996) 1.20
A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome. Nature (1987) 1.20
Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma. J Natl Cancer Inst (1992) 1.16
Clinicopathological prognostic factors in soft tissue leiomyosarcoma: a multivariate analysis. Histopathology (2002) 1.15
Oversecretion of IL-18 in haemophagocytic lymphohistiocytosis: a novel marker of disease activity. Br J Haematol (1999) 1.15
A clinicopathological study in young patients with gastric carcinoma. J Surg Oncol (1999) 1.15
Hemophagocytic syndrome associated with fulminant ulcerative colitis and presumed acute pancreatitis. Am J Gastroenterol (1998) 1.13
Dominant negative isoform of the Ikaros gene in patients with adult B-cell acute lymphoblastic leukemia. Cancer Res (2000) 1.12
Antagonistic effects of an alternative splice variant of human IL-4, IL-4delta2, on IL-4 activities in human monocytes and B cells. Cell Immunol (1999) 1.10
Outside-to-inside signal through the membrane TNF-alpha induces E-selectin (CD62E) expression on activated human CD4+ T cells. J Immunol (2001) 1.10
Association of tumor necrosis factor receptor type II polymorphism 196R with Systemic lupus erythematosus in the Japanese: molecular and functional analysis. Arthritis Rheum (2001) 1.10
Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small-cell lung carcinoma. Oncogene (1992) 1.10
Autologous peripheral blood stem cell transplantation for acute myelogenous leukemia. Bone Marrow Transplant (1997) 1.10
Radiofrequency catheter ablation of left ventricular outflow tract tachycardia: report of two cases. J Cardiovasc Electrophysiol (1998) 1.10
Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities. Ann Rheum Dis (1989) 1.10
Establishment of an embryonic stem (ES) cell line derived from a non-obese diabetic (NOD) mouse: in vivo differentiation into lymphocytes and potential for germ line transmission. FEBS Lett (1999) 1.08
Interleukin-10 selectively inhibits osteoclastogenesis by inhibiting differentiation of osteoclast progenitors into preosteoclast-like cells in rat bone marrow culture system. J Cell Physiol (1995) 1.07
IL-10 inhibits prostaglandin E2 production by lipopolysaccharide-stimulated monocytes. Int Immunol (1994) 1.07
Hepatitis C virus infection in institutionalized psychiatric patients: possible role of transmission by razor sharing. Dig Dis Sci (2000) 1.07
Proliferative involvement of ENX-1, a putative human polycomb group gene, in haematopoietic cells. Br J Haematol (2000) 1.06
Association of IFN-gamma and IFN regulatory factor 1 polymorphisms with childhood atopic asthma. J Allergy Clin Immunol (2001) 1.06
Sequential development of structural and functional alterations in T cells from tumor-bearing mice. J Immunol (1997) 1.05
Activation of STAT5 by lipopolysaccharide through granulocyte-macrophage colony-stimulating factor production in human monocytes. J Immunol (1998) 1.05
Changes of telomere length in children after hematopoietic stem cell transplantation. Bone Marrow Transplant (1998) 1.05
Cellular characteristics of neoplastic angioendotheliosis. An immunohistological marker study of 6 cases. Virchows Arch A Pathol Anat Histopathol (1985) 1.05
Serum concentration of the soluble interleukin-2 receptor for monitoring acute graft-versus-host disease. Bone Marrow Transplant (1996) 1.04
Interleukin-11 enhances human megakaryocytopoiesis in vitro. Blood (1992) 1.03
Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia. Cancer Res (1999) 1.03
An early gastric carcinoma treatment strategy based on analysis of lymph node metastasis. Cancer (1999) 1.03
Effect of IL-10 on collagen-induced arthritis in mice. Inflamm Res (1996) 1.03
Establishment of a human leukaemic cell line (CMK) with megakaryocytic characteristics from a Down's syndrome patient with acute megakaryoblastic leukaemia. Br J Haematol (1989) 1.03
Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas. Clin Cancer Res (2000) 1.03
Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine. J Immunol (1993) 1.02
Clinical importance of persistence of anticardiolipin antibodies in systemic lupus erythematosus. Ann Rheum Dis (1990) 1.02
Epstein-Barr virus BCRF1 gene product (viral interleukin 10) inhibits superoxide anion production by human monocytes. Lymphokine Cytokine Res (1992) 1.02
Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporine-dependent aplastic anemia. Blood (1994) 1.01
Regulation by interleukin-10 and interleukin-4 of cyclooxygenase-2 expression in human neutrophils. Blood (1997) 1.01
Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction. Bone Marrow Transplant (2002) 1.01
Association of the interferon-gamma receptor variant (Val14Met) with systemic lupus erythematosus. Immunogenetics (1999) 1.00
Bradykinin and respiratory mucous membranes. Analysis of bradykinin binding site distribution and secretory responses in vitro and in vivo. Am Rev Respir Dis (1990) 1.00
Prognostic value of the preserved expression of the E-cadherin and catenin families of adhesion molecules and of beta-catenin mutations in synovial sarcoma. J Pathol (2000) 1.00
Immunohistochemical localization of vascular endothelial growth factor in the human placenta. Placenta (1996) 1.00
Analysis of a questionnaire on adverse reactions to blood donation in Japan. Transfus Apher Sci (2012) 1.00
High incidence of herpes zoster in patients with systemic lupus erythematosus: an immunological analysis. Ann Rheum Dis (1990) 1.00
Implications of the NR2B subunit-containing NMDA receptor localized in mouse limbic forebrain in ethanol dependence. Eur J Pharmacol (2000) 0.99
Point mutation of the p53 gene resulting in splicing inhibition in small cell lung carcinoma. Biochem Biophys Res Commun (1990) 0.99
Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood (1995) 0.99
Maturational alterations of peripheral T cell subsets and cytokine gene expression in 22q11.2 deletion syndrome. Clin Exp Immunol (2006) 0.99
Cutaneous extramedullary hematopoiesis in myelofibrosis. J Am Acad Dermatol (1990) 0.99
Association between birthweight and body mass index at 3 years of age. Pediatr Int (2001) 0.99